Clinical Trial Update: Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 trial investigating expanded and activated autologous NK cells for treating multiple myeloma has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• autologous NK cells (expanded and activated)

Snippet

Sponsor: Joaquín Martínez López, MD, PhD | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2016-12-05